Press Releases

PExA strengthens its position in vaccine development – patent application based on research highlighted in a Lancet journal

PExA has filed a European patent application covering new methods for measuring and monitoring immune responses in the lower airways of the lungs. The application is based on research and method development conducted in collaboration with Professor Charlotte Thålin at Karolinska Institutet and Associate Professor Mikael Åberg at SciLifeLab, Uppsala University. The research findings were…

Read more

Vaccine Research Using PExA Technology Featured on the Cover of a Lancet Journal

The study recently announced by PExA AB (publ), in which researchers demonstrated that virus-specific antibodies from the lungs’ small airways can be analyzed non-invasively using the company’s technology, is now also featured on the cover of the November issue of eBioMedicine. The journal is internationally recognized as a leading publication in biomedicine, is part of…

Read more

New Lancet journal study shows virus-specific antibodies can be measured deep in the lungs without bronchoscopy

A new scientific study by researchers at Karolinska Institutet, Danderyd Hospital and Uppsala University demonstrates that samples collected non-invasively using PExA can be used to measure virus-specific antibodies from the small airways. Published in eBioMedicine, one of the leading international scientific journals in biomedicine and part of The Lancet Discovery Science, the study opens new…

Read more

Breakthrough study strengthens evidence for non-invasive sampling of the lung’s small airways

An Australian study shows that PExA’s non-invasive lung sampling technology captures hundreds of proteins also found through invasive bronchoalveolar lavage (BAL)—a resource-intensive procedure involving patient burden and procedural risks. The findings provide strong support for PExA’s ability to capture biologically relevant molecular information from the small airways. The company regards the study as a major…

Read more

PExA Strengthens Its International Patent Portfolio with Positive Patent Decisions in Europe and China

PExA AB (publ) has been granted a European patent that strengthens the company’s intellectual property protection in the field of mechanical ventilation. At the same time, the company has received positive patent decisions in both Europe and China concerning a sample preparation technology. These developments strengthen PExA’s international patent portfolio, which covers both the company’s…

Read more